Pediatric Neurology 2012-04-01

Recurrent COLQ mutation in congenital myasthenic syndrome.

Alev Guven, Mehmet Demirci, Banu Anlar

Index: Pediatr. Neurol. 46(4) , 253-6, (2012)

Full Text: HTML

Abstract

Congenital myasthenic syndromes comprise clinically and genetically heterogeneous disorders resulting from presynaptic, synaptic, or postsynaptic defects. Mutations in the COLQ gene result in acetylcholinesterase deficiency and cause a rare, autosomal recessive synaptic form of congenital myasthenic syndrome, with variable age of onset and clinical severity. We present four unrelated patients with a homozygous W148X mutation in the COLQ gene. Signs began at birth in all, but subsequent severity ranged from independent ambulation to wheelchair use during childhood. Treatment was partly effective; one patient was asymptomatic with 3,4-diaminopyridine treatment. These cases illustrate the clinical features and treatment results associated with this particular genotype, which appears to be relatively frequent among Turkish patients with congenital myasthenic syndrome.Copyright © 2012 Elsevier Inc. All rights reserved.


Related Compounds

Related Articles:

Novel HPLC--Fluorescence methodology for the determination of methylglyoxal and glyoxal. Application to the analysis of monovarietal wines "Ribera del Guadiana".

2015-11-15

[Food Chem. 187 , 159-65, (2015)]

Ectopic uterine tissue as a chronic pain generator.

2012-12-06

[Neuroscience 225 , 269-82, (2012)]

3-D-QSAR and docking studies on the neuronal choline transporter.

2010-08-15

[Bioorg. Med. Chem. Lett. 20 , 4870-7, (2010)]

Acute and chronic effects of botulinum neurotoxin a on the mammalian neuromuscular junction.

2014-08-01

[Muscle Nerve 50(2) , 206-15, (2014)]

Orphan drugs. BioMarin Europe replies.

2010-01-01

[BMJ 341 , c7006, (2010)]

More Articles...